-
公开(公告)号：US20170253554A1
公开(公告)日：2017-09-07
申请号：US15509214
申请日：2015-09-08
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Yan Shi , Peter T.W. Cheng , Ying Wang , Sutjano Jusuf , Shiwei Tao , Hao Zhang , Shung C. Wu , Jeffrey A. Robl
IPC: C07C62/34 , A61K31/192 , C07D307/79 , A61K31/343 , C07D277/30 , A61K31/44 , C07D213/55 , A61K31/4418 , C07D231/12 , A61K31/415 , C07D213/65 , A61K45/06 , A61K31/426
CPC classification number: C07C62/34 , A61K31/192 , A61K31/343 , A61K31/415 , A61K31/426 , A61K31/44 , A61K31/4418 , C07C59/64 , C07C2601/02 , C07D207/323 , C07D213/55 , C07D213/65 , C07D231/12 , C07D277/30 , C07D277/593 , C07D307/79 , C07D307/82
Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein coupled receptor modulators which may be used as medicaments
-
公开(公告)号：US20250057995A1
公开(公告)日：2025-02-20
申请号：US18732745
申请日：2024-06-04
Applicant: Bristol-Myers Squibb Company
Inventor： Peter Tai Wah Cheng , James R. Corte , David J. Donnelly , Joonyoung Kim , Jun Shi , Shiwei Tao , Tritin Tran
IPC: A61K51/04 , C07D401/04
Abstract: The present invention relates to radiolabeled LPA1 receptor antagonists of Formula (I): or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein, which are useful for the quantitative imaging of LPA1 receptors in mammals.
-
公开(公告)号：US12195444B2
公开(公告)日：2025-01-14
申请号：US18321092
申请日：2023-05-22
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Yan Shi , Peter Tai Wah Cheng , Ying Wang , Jun Shi , Shiwei Tao , Jun Li , Lawrence J. Kennedy , Robert F. Kaltenbach, III , Hao Zhang , James R. Corte
IPC: C07D401/04 , A61P1/16 , A61P11/00 , A61P13/12 , A61P19/10 , A61P35/00 , C07C249/06 , C07C403/04 , C07D249/06 , C07D403/04
Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US20220249443A1
公开(公告)日：2022-08-11
申请号：US17718760
申请日：2022-04-12
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: A61K31/4192 , C07D401/14 , C07D249/06 , A61K31/27 , A61K31/454 , C07D401/04
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US20220235027A1
公开(公告)日：2022-07-28
申请号：US17617611
申请日：2020-06-16
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： YAN SHI , Ying Wang , Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun Shi , Shiwei Tao
IPC: C07D401/04 , C07D401/14 , C07D413/14
Abstract: The present invention provides compounds of Formula (I): (I), or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
Patent Agency Ranking
公开(公告)号：US20220235026A1
公开(公告)日：2022-07-28
申请号：US17617322
申请日：2020-06-16
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Peter Tai Wah Cheng , Hao Zhang , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Shiwei Tao , Yan Shi
IPC: C07D401/04 , C07D413/14 , C07D405/14 , C07D401/14
Abstract: The present invention provides compounds of Formula (I), or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US11267800B2
公开(公告)日：2022-03-08
申请号：US16772825
申请日：2018-12-18
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Yan Shi , Ying Wang , Peter Tai Wah Cheng , Jun Shi , Shiwei Tao , James R. Corte , Tianan Fang , Jun Li , Lawrence J. Kennedy , Robert F. Kaltenbach, III , Sutjano Jusuf
IPC: C07D401/14 , C07D401/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D491/052
Abstract: The present invention provides compounds of Formula (I): Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US20210163470A1
公开(公告)日：2021-06-03
申请号：US16772842
申请日：2018-12-18
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Yan Shi , Peter Tai Wah Cheng , Ying Wang , Jun Li , Tianan Fang , James R. Corte , Jun Shi , Hao Zhang , Lawrence J. Kennedy , Shiwei Tao
IPC: C07D417/14 , C07D401/14 , C07D413/14 , C07D403/14
Abstract: The present invention provides compounds of Formula (I): Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US10576062B2
公开(公告)日：2020-03-03
申请号：US16038739
申请日：2018-07-18
Applicant: Bristol-Myers Squibb Company
Inventor： Peter Tai Wah Cheng , Robert F. Kaltenbach, III , Jun Li , Jun Shi , Yan Shi , Shiwei Tao , Hao Zhang , Suresh Dhanusu , Kumaravel Selvakumar , Ramesh Babu Reddigunta , Steven J. Walker , Lawrence J. Kennedy , James R. Corte , Tianan Fang , Sutjano Jusuf
IPC: C07D401/14 , C07D249/06 , A61K31/27 , A61K31/4192 , A61K31/454 , C07D401/04 , A61K31/41 , C07C62/10
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
-
公开(公告)号：US09938222B2
公开(公告)日：2018-04-10
申请号：US15509214
申请日：2015-09-08
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Yan Shi , Peter T. W. Cheng , Ying Wang , Sutjano Jusuf , Shiwei Tao , Hao Zhang , Shung C. Wu , Jeffrey A. Robl
IPC: C07C62/34 , C07C59/64 , C07D307/79 , C07D277/30 , C07D213/55 , C07D231/12 , C07D213/65
CPC classification number: C07C62/34 , A61K31/192 , A61K31/343 , A61K31/415 , A61K31/426 , A61K31/44 , A61K31/4418 , C07C59/64 , C07C2601/02 , C07D207/323 , C07D213/55 , C07D213/65 , C07D231/12 , C07D277/30 , C07D277/593 , C07D307/79 , C07D307/82
Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.
-
-
-
-
-
-
-
-
-
Search Results
32
records
(took 0.032 seconds)
